Genomic Assessment of Cancer-Predisposition Landscape of Pediatric Rhabdomyosarcoma
December 30, 2020
December 30, 2020
HOUSTON, Texas, Dec. 30 (TNSJou) -- The Baylor College of Medicine issued the following news release:
Rhabdomyosarcoma (RMS) is a highly malignant tumor and the most common soft tissue sarcoma in children. In spite of its clinical significance, less is known about genetic susceptibility to this malignancy compared to other pediatric cancers. Researchers at Baylor College of Medicine led the largest genomic assessment of children with RMS to determine the prevalence of genetic change . . .
Rhabdomyosarcoma (RMS) is a highly malignant tumor and the most common soft tissue sarcoma in children. In spite of its clinical significance, less is known about genetic susceptibility to this malignancy compared to other pediatric cancers. Researchers at Baylor College of Medicine led the largest genomic assessment of children with RMS to determine the prevalence of genetic change . . .